2-chloro-n(6)cyclopentyladenosine has been researched along with rocuronium in 1 studies
| Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (rocuronium) | Trials (rocuronium) | Recent Studies (post-2010) (rocuronium) |
|---|---|---|---|---|---|
| 252 | 0 | 43 | 2,157 | 766 | 1,077 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamata, M; Namiki, A; Narimatsu, E; Niiya, T | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and rocuronium
| Article | Year |
|---|---|
Adenosine and adenosine uptake inhibitors potentiate the neuromuscular blocking action of rocuronium mediated by adenosine A(1) receptors in isolated rat diaphragms.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Androstanols; Animals; Diaphragm; Dipyridamole; Drug Synergism; Electric Stimulation; Male; Midazolam; Models, Animal; Neuromuscular Blocking Agents; Phenethylamines; Rats; Rats, Wistar; Receptor, Adenosine A1; Rocuronium; Xanthines | 2008 |